Pursuant to the Regulation 29 (1) (a) read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Tatva Chintan Pharma Chem has informed that the Meeting of the Board of Directors of the company is scheduled to be held on Monday, 17 January, 2022, to: Consider and approve the unaudited standalone financial results of the Company for the quarter/ nine months ended 31 December, 2021 and Consider and approve the unaudited consolidated financial results of the Company for the quarter /nine months ended 31 December 2021.
The above information is a part of company’s filings submitted to BSE.
